Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luisa Minghetti

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Current Pharmaceutical Design|June 10, 2008
Cyclooxygenases and cyclooxygenase inhibitors in neurological and psychiatric diseasesLuisa Minghetti
Journal of Neuropathology and Experimental Neurology|September 30, 2004
Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseasesLuisa Minghetti
Sub-Cellular Biochemistry|July 7, 2007
Role of COX-2 in inflammatory and degenerative brain diseasesLuisa Minghetti
Current Opinion in Neurology|May 14, 2005
Role of inflammation in neurodegenerative diseasesLuisa Minghetti
International Review of Neurobiology|August 7, 2007
Cyclooxygenase-2, prostaglandin E2, and microglial activation in prion diseasesLuisa Minghetti, Maurizio Pocchiari
Current Pharmaceutical Design|February 4, 2006
PPAR-gamma agonists as regulators of microglial activation and brain inflammationAntonietta Bernardo, Luisa Minghetti
PPAR Research|May 10, 2008
Regulation of Glial Cell Functions by PPAR-gamma Natural and Synthetic AgonistsAntonietta Bernardo, Luisa Minghetti
Current Neurovascular Research|September 27, 2005
Isoprostanes as biomarkers and mediators of oxidative injury in infant and adult central nervous system diseasesAnita Greco, Luisa Minghetti
Annali Dell'Istituto Superiore Di Sanita|December 21, 2020
A few ethical issues in translational research for medicinal products discovery and developmentCarlo Petrini, Luisa Minghetti, Silvio Brusaferro
Nutrients|August 23, 2020
Interaction between Gut Microbiota and Curcumin: A New Key of Understanding for the Health Effects of CurcuminBeatrice Scazzocchio, Luisa Minghetti, Massimo D'Archivio
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Current Pharmaceutical Design|June 10, 2008
Cyclooxygenases and cyclooxygenase inhibitors in neurological and psychiatric diseasesLuisa Minghetti
Journal of Neuropathology and Experimental Neurology|September 30, 2004
Cyclooxygenase-2 (COX-2) in inflammatory and degenerative brain diseasesLuisa Minghetti
Sub-Cellular Biochemistry|July 7, 2007
Role of COX-2 in inflammatory and degenerative brain diseasesLuisa Minghetti
Current Opinion in Neurology|May 14, 2005
Role of inflammation in neurodegenerative diseasesLuisa Minghetti
International Review of Neurobiology|August 7, 2007
Cyclooxygenase-2, prostaglandin E2, and microglial activation in prion diseasesLuisa Minghetti, Maurizio Pocchiari
Current Pharmaceutical Design|February 4, 2006
PPAR-gamma agonists as regulators of microglial activation and brain inflammationAntonietta Bernardo, Luisa Minghetti
PPAR Research|May 10, 2008
Regulation of Glial Cell Functions by PPAR-gamma Natural and Synthetic AgonistsAntonietta Bernardo, Luisa Minghetti
Current Neurovascular Research|September 27, 2005
Isoprostanes as biomarkers and mediators of oxidative injury in infant and adult central nervous system diseasesAnita Greco, Luisa Minghetti
Annali Dell'Istituto Superiore Di Sanita|December 21, 2020
A few ethical issues in translational research for medicinal products discovery and developmentCarlo Petrini, Luisa Minghetti, Silvio Brusaferro
Nutrients|August 23, 2020
Interaction between Gut Microbiota and Curcumin: A New Key of Understanding for the Health Effects of CurcuminBeatrice Scazzocchio, Luisa Minghetti, Massimo D'Archivio
Pageof 9